Medprin Long Term Debt vs Net Invested Capital Analysis

301033 Stock   43.00  0.18  0.42%   
Medprin Regenerative financial indicator trend analysis is infinitely more than just investigating Medprin Regenerative recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medprin Regenerative is a good investment. Please check the relationship between Medprin Regenerative Long Term Debt and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Long Term Debt vs Net Invested Capital

Long Term Debt vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medprin Regenerative Long Term Debt account and Net Invested Capital. At this time, the significance of the direction appears to have weak relationship.
The correlation between Medprin Regenerative's Long Term Debt and Net Invested Capital is 0.33. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Medprin Regenerative Medical, assuming nothing else is changed. The correlation between historical values of Medprin Regenerative's Long Term Debt and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Medprin Regenerative Medical are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Long Term Debt i.e., Medprin Regenerative's Long Term Debt and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.33
Relationship DirectionPositive 
Relationship StrengthVery Weak

Long Term Debt

Long-term debt is a debt that Medprin Regenerative has held for over one year. Long-term debt appears on Medprin Regenerative Medical balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Medprin Regenerative Medical balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from Medprin Regenerative's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medprin Regenerative current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
As of January 10, 2025, Tax Provision is expected to decline to about 6.1 M. In addition to that, Selling General Administrative is expected to decline to about 57.7 M
 2022 2023 2024 2025 (projected)
Gross Profit164.0M189.3M217.7M149.6M
Total Revenue195.3M230.9M265.5M179.7M

Medprin Regenerative fundamental ratios Correlations

-0.890.941.00.950.880.010.980.890.820.980.620.940.95-0.960.971.00.730.980.250.980.97-0.130.3-0.860.97
-0.89-0.91-0.85-0.86-0.970.25-0.84-0.74-0.69-0.83-0.72-0.96-0.790.98-0.97-0.89-0.78-0.83-0.36-0.84-0.8-0.05-0.440.68-0.78
0.94-0.910.920.930.930.120.960.90.820.90.420.860.95-0.950.930.930.540.90.00.930.93-0.350.1-0.860.92
1.0-0.850.920.950.840.080.980.90.830.990.570.90.97-0.930.940.990.690.990.20.980.99-0.170.25-0.880.98
0.95-0.860.930.950.870.060.950.960.940.950.520.870.93-0.950.920.950.650.950.070.960.95-0.250.13-0.950.95
0.88-0.970.930.840.87-0.240.850.750.770.810.620.930.79-0.960.960.870.690.810.20.870.79-0.090.25-0.720.79
0.010.250.120.080.06-0.240.170.320.110.09-0.65-0.320.310.12-0.190.0-0.530.09-0.70.060.23-0.77-0.57-0.290.23
0.98-0.840.960.980.950.850.170.930.850.960.440.860.99-0.920.920.970.570.960.050.990.99-0.330.11-0.910.99
0.89-0.740.90.90.960.750.320.930.940.90.30.720.95-0.860.80.880.450.9-0.150.910.95-0.46-0.06-0.990.95
0.82-0.690.820.830.940.770.110.850.940.830.320.710.83-0.810.770.810.450.83-0.160.890.87-0.41-0.15-0.970.88
0.98-0.830.90.990.950.810.090.960.90.830.590.890.96-0.910.920.990.721.00.210.970.98-0.140.27-0.880.97
0.62-0.720.420.570.520.62-0.650.440.30.320.590.810.37-0.650.710.630.980.590.860.510.430.690.85-0.260.42
0.94-0.960.860.90.870.93-0.320.860.720.710.890.810.79-0.960.990.940.880.890.490.890.830.160.51-0.690.82
0.95-0.790.950.970.930.790.310.990.950.830.960.370.79-0.890.870.950.510.96-0.020.950.99-0.390.07-0.920.99
-0.960.98-0.95-0.93-0.95-0.960.12-0.92-0.86-0.81-0.91-0.65-0.96-0.89-0.99-0.95-0.74-0.91-0.26-0.92-0.90.08-0.330.82-0.89
0.97-0.970.930.940.920.96-0.190.920.80.770.920.710.990.87-0.990.970.80.920.350.930.890.00.4-0.770.88
1.0-0.890.930.990.950.870.00.970.880.810.990.630.940.95-0.950.970.750.990.270.970.97-0.10.33-0.850.96
0.73-0.780.540.690.650.69-0.530.570.450.450.720.980.880.51-0.740.80.750.720.780.630.580.570.79-0.410.57
0.98-0.830.90.990.950.810.090.960.90.831.00.590.890.96-0.910.920.990.720.210.970.98-0.140.27-0.880.97
0.25-0.360.00.20.070.2-0.70.05-0.15-0.160.210.860.49-0.02-0.260.350.270.780.210.10.050.910.960.180.03
0.98-0.840.930.980.960.870.060.990.910.890.970.510.890.95-0.920.930.970.630.970.10.97-0.260.12-0.910.98
0.97-0.80.930.990.950.790.230.990.950.870.980.430.830.99-0.90.890.970.580.980.050.97-0.320.11-0.931.0
-0.13-0.05-0.35-0.17-0.25-0.09-0.77-0.33-0.46-0.41-0.140.690.16-0.390.080.0-0.10.57-0.140.91-0.26-0.320.860.48-0.33
0.3-0.440.10.250.130.25-0.570.11-0.06-0.150.270.850.510.07-0.330.40.330.790.270.960.120.110.860.130.09
-0.860.68-0.86-0.88-0.95-0.72-0.29-0.91-0.99-0.97-0.88-0.26-0.69-0.920.82-0.77-0.85-0.41-0.880.18-0.91-0.930.480.13-0.94
0.97-0.780.920.980.950.790.230.990.950.880.970.420.820.99-0.890.880.960.570.970.030.981.0-0.330.09-0.94
Click cells to compare fundamentals

Medprin Regenerative Account Relationship Matchups

Medprin Regenerative fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets455.3M746.8M744.9M787.0M905.0M676.3M
Other Current Liab699.4K452.1K608.6K809.4K728.5K657.1K
Total Current Liabilities58.1M54.2M81.8M68.1M78.3M65.0M
Total Stockholder Equity334.4M572.3M602.6M635.9M731.2M537.7M
Retained Earnings21.7M63.2M89.6M114.0M131.1M137.7M
Accounts Payable36.6M32.7M32.7M31.9M36.7M33.9M
Cash11.7M10.4M45.0M26.7M30.7M26.9M
Non Current Assets Total202.8M329.6M506.7M517.3M594.8M368.2M
Non Currrent Assets Other655.2K12.1M58.0M55.2M63.5M66.7M
Net Receivables7.7M5.3M10.4M18.1M20.8M21.8M
Short Term Investments199.3M375.6M147.1M192.8M221.7M234.9M
Non Current Liabilities Total59.1M116.7M60.6M83.0M95.4M71.2M
Inventory16.5M21.2M29.4M26.2M30.1M24.0M
Other Current Assets6.8M642.3K462.4K70.1K63.1K60.0K
Total Liab117.3M170.9M142.3M151.1M173.8M136.2M
Net Invested Capital381.9M673.9M652.9M682.3M784.6M591.8M
Total Current Assets252.6M417.1M238.2M269.7M310.2M308.1M
Net Working Capital194.4M363.0M156.5M201.6M181.4M176.8M
Intangible Assets62.9M76.2M82.8M94.2M108.4M80.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Medprin Stock

Balance Sheet is a snapshot of the financial position of Medprin Regenerative at a specified time, usually calculated after every quarter, six months, or one year. Medprin Regenerative Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medprin Regenerative and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medprin currently owns. An asset can also be divided into two categories, current and non-current.